No black box warning on record for Nulibry

As of the latest FDA labeling reviewed, Nulibry (FOSDENOPTERIN HYDROBROMIDE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Nulibry medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Potential for Photosensitivity : Advise patients/caregivers to avoid patient exposure to sunlight, and to have the patient wear sunscreen, protective clothing, and sunglasses when exposed to the sun. If photosensitivity occurs, advise caregivers/patients to seek medical attention immediately and consider a dermatological evaluation. ( 5.1 , 13.2 ) 5.1 Potential for Photo

No black box warning on record for Nulibry

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Potential for Photosensitivity : Advise patients/caregivers to avoid patient exposure to sunlight, and to have the patient wear sunscreen, protective clothing, and sunglasses when exposed to the sun. If photosensitivity occurs, advise caregivers/patients to seek medical attention immediately and consider a dermatological evaluation. ( 5.1 , 13.2 ) 5.1 Potential for Photo

Nulibry Black Box Warning

No black box warning on record for Nulibry

Other warnings & precautions

Nulibry Black Box Warning

No black box warning on record for Nulibry

Other warnings & precautions